{"Title": "Clinical players and healthcare payers: Aligning perspectives on the cost-effectiveness of next-generation sequencing in oncology", "Year": 2015, "Source": "Personalized Med.", "Volume": "12", "Issue": 1, "Art.No": null, "PageStart": 9, "PageEnd": 12, "CitedBy": 3, "DOI": "10.2217/pme.14.81", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84920816380&origin=inward", "Abstract": null, "AuthorKeywords": ["cancer", "clinical tumor sequencing", "cost-effectiveness analysis", "economic evaluation", "reimbursement", "value assessment", "whole-genome sequencing"], "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-84920816380", "SubjectAreas": [["Molecular Medicine", "BIOC", "1313"], ["Pharmacology", "PHAR", "3004"]], "AuthorData": {"54786343600": {"Name": "Doble B.", "AuthorID": "54786343600", "AffiliationID": "60116267, 60019578", "AffiliationName": "Centre for Health Economics, Monash Business School, Monash University"}, "14038950500": {"Name": "Lorgelly P.", "AuthorID": "14038950500", "AffiliationID": "60116267, 60019578", "AffiliationName": "Centre for Health Economics, Monash Business School, Monash University"}}}